Global Anatomical Pathology Market Forecast to 2026: Increasing Number of Clinical Trials Related to Cancer Drugs

Dublin, November 26, 2021– (work wire)–The Anatomical Pathology Market by product, service, application, end user, and region – Global Forecast to 2026 Report added to ResearchAndMarkets.com an offer.

The global anatomic pathology market is expected to reach US$49.1 billion by 2026 from US$35.1 billion in 2021, at a compound annual growth rate of 7%.

The growth of the anatomical pathology market is mainly driven by the rising incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and a growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to provide significant growth opportunities for players operating in the anatomical pathology market during the forecast period.

The Anatomical Pathology Services segment represented the highest growth rate in the Anatomical Pathology market, by product and service, during the forecast period

On the basis of product and service, the Anatomical Pathology market is segmented into services, consumables, and tools. The Anatomical Pathology Services segment is expected to register the highest compound annual growth rate (CAGR) during the forecast period. The growth of this segment is primarily due to the rapid growth in the elderly population and the increase in the incidence of cancer and other chronic diseases.

Disease diagnoses represent the highest compound annual growth rate

Based on the application, the anatomical pathology market is segmented into disease diagnostics and medical research. The diagnostics segment is expected to register the highest compound annual growth rate (CAGR) during the forecast period. This can be attributed to the rise in the number of elderly people and the increase in the incidence of cancer and other chronic diseases.

Hospital laboratories accounted for the highest compound annual growth rate

Based on the end user, the Anatomic Pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital laboratories are expected to register the highest compound annual growth rate (CAGR) during the forecast period. Increasing number of patient visits to hospitals, increasing number of internal diagnostic procedures being performed in hospitals, and growing awareness regarding early diagnosis of diseases are major factors contributing to the growth of this sector.

Asia Pacific: The Fastest Growing Region in Anatomical Pathology Market

The Anatomical Pathology market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The Asia Pacific region presents high growth opportunities for players in the Anatomical Pathology market. Presence of emerging economies such as China and India, large populations of countries in the Asia-Pacific region, increased prevalence of chronic diseases, improvement in standard of living, growing demand for quality medical care, increased spending on health care and government initiatives, and increased awareness about the use of anatomical medicines. Pathology examinations among physicians are among the major factors driving the market growth in the Asia Pacific region.

Research coverage

This report provides a detailed picture of the Anatomic Pathology market. It aims to estimate the size and future growth potential of the market across different segments, such as product, service, application, end user, and region. The report also includes an in-depth competitive analysis of the major market players, along with company profiles, recent developments, and key market strategies.

market dynamics

  • drivers

    • High incidence of cancer and other target diseases

    • Cancer screening recommendations

    • Payment Availability

    • Increasing focus on personalized medicine

  • chances

  • Challenges

    • Availability of refurbished products

    • Lack of skilled professionals

    • Product failures and recalls

    • Inadequate infrastructure and poor awareness in middle and low income countries

  • trends

Company Profile

  • Abcam plc

  • Agilent Technologies

  • Amos Scientific Pty. Ltd.

  • Becton, Dickinson & Co

  • Bio SB

  • Biogenex

  • Bright Instruments

  • Cell Signaling Technology

  • Cellpath Ltd.

  • Danaher Corporation

  • Diapath Spa

  • F. Hoffman-La Roche Ltd.

  • Histo Line Laboratories

  • Hologic, Inc.

  • Jinhua Yidi Medical Devices Co., Ltd.

  • your lobe

  • media

  • Medite Medical GmbH

  • Merck KGaA

  • Micros Austria

  • Milestone Medical

  • PHC Holding Company

  • RK Scientific Instrument Private Limited

  • Sakura Pinetech USA Inc.

  • Sleep Medical GmbH

For more information about this report visit https://www.researchandmarkets.com/r/9qh8pl

View the source version on businesswire.com: https://www.businesswire.com/news/home/20211126005432/ar/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Director of Press
[email protected]
For EST office hours, call 1-917-300-0470
For US/Canada Toll Free Call 1-800-526-8630
For GMT office hours, call +353-1-416-8900

Write a Comment

Your email address will not be published. Required fields are marked *